{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:00:32Z","timestamp":1788238832210,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Health, Labour and Welfare, Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This meta-analysis aimed to evaluate the device performance of conventional balloon catheters (POBA), drug-coated balloons (DCB), bare-metal stents (BMS), and drug-eluting stents (DES) in below-the-knee (BTK) ischemic lesions with regard to lesion characteristics. Online searches of PubMed, Web of Science, and Cochrane databases (2010\u20132019) were conducted for each of the test devices. Primary patency rates (pp) and major amputation rates 1\u00a0year after the use of each device were analyzed using a random-effects meta-analysis model. Meta-regression analysis was conducted to test associations between the outcomes and lesion characteristics. The analysis included 18 studies reporting on 24 separate cohorts comprising 2,438 patients. DES demonstrated the best pp among the test devices (83.6%; 95% confidence interval\u2009=\u200978.4\u201388.8%, studies\u2009=\u20098; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200966%, <jats:italic>P<\/jats:italic>\u2009=\u20090.005). A negative coefficient between lesion length and pp (<jats:italic>P<\/jats:italic>\u2009=\u20090.002) was obtained. The ratio of critical limb ischemia (CLI) patients impacted the amputation rates (<jats:italic>P<\/jats:italic>\u2009=\u20090.031), whereas no statistically significant difference was found between the devices. DES showed favorable pp in BTK lesions; however, as the lesion lengths using DES were short, pp in long lesions still needs to be evaluated. Shorter lesions gained better pp. A higher ratio of CLI patients resulted in increased amputation rates.<\/jats:p>","DOI":"10.1007\/s12928-021-00758-7","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T22:44:28Z","timestamp":1612824268000},"page":"145-157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Comparative performance analysis of interventional devices for the treatment of ischemic disease in below-the-knee lesions: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"37","author":[{"given":"Emi Kearon","family":"Matsuoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terumitsu","family":"Hasebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Soejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3994-5509","authenticated-orcid":false,"given":"Kiyotaka","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,6]]},"reference":[{"key":"758_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1583\/09-2691.1","volume":"16","author":"GGL Biondi-Zoccai","year":"2009","unstructured":"Biondi-Zoccai GGL, Sangiorgi G, Lotrionte M, Feiring A, Commeau P, Fusaro M, et al. Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther. 2009;16:251\u201360.","journal-title":"J Endovasc Ther."},{"key":"758_CR2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jcin.2013.08.007","volume":"6","author":"M Fusaro","year":"2013","unstructured":"Fusaro M, Cassese S, Ndrepepa G, Tepe G, King L, Ott I, et al. Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials. JACC Cardiovasc Interv. 2013;6:1284\u201393.","journal-title":"JACC Cardiovasc Interv."},{"key":"758_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.23736\/S0392-9590.19.04049-5","volume":"38","author":"RL Varcoe","year":"2019","unstructured":"Varcoe RL, Paravastu SC, Thomas SD, Bennett MH. The use of drug-eluting stents in infrapopliteal arteries: an updated systematic review and meta-analysis of randomized trials. Int Angiol. 2019;38:121\u201335.","journal-title":"Int Angiol."},{"key":"758_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1177\/1526602816671740","volume":"23","author":"K Katsanos","year":"2016","unstructured":"Katsanos K, Kitrou P, Spiliopoulos S, Diamantopoulos A, Karnabatidis D. Comparative effectiveness of plain balloon angioplasty, bare metal stents, drug-coated balloons, and drug-eluting stents for the treatment of infrapopliteal artery disease: systematic review and Bayesian network meta-analysis of randomized controlled trials. J Endovasc Ther. 2016;23:851\u201363.","journal-title":"J Endovasc Ther."},{"key":"758_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","volume":"26","author":"RB Rutherford","year":"1997","unstructured":"Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517\u201338.","journal-title":"J Vasc Surg."},{"key":"758_CR6","unstructured":"QUADAS-2. University of Bristol. http:\/\/www.bristol.ac.uk\/population-health-sciences\/projects\/quadas\/quadas-2\/. Accessed 3 Nov 2020."},{"key":"758_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v049.i05","volume":"49","author":"BC Wallace","year":"2012","unstructured":"Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH. Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Softw. 2012;49:1\u201315.","journal-title":"J Stat Softw."},{"key":"758_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.113.001811","volume":"128","author":"F Liistro","year":"2013","unstructured":"Liistro F, Porto I, Angioli P, Grotti S, Ricci L, Ducci K, et al. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation. 2013;128:615\u201321.","journal-title":"Circulation"},{"key":"758_CR9","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1161\/CIRCULATIONAHA.113.001849","volume":"127","author":"A Rastan","year":"2013","unstructured":"Rastan A, Krankenberg H, Baumgartner I, Blessing E, Muller-Hulsbeck S, Pilger E, et al. Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial. Circulation. 2013;127:2535\u201341.","journal-title":"Circulation"},{"key":"758_CR10","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jvs.2013.04.024","volume":"58","author":"KE Todd Jr","year":"2013","unstructured":"Todd KE Jr, Ahanchi SS, Maurer CA, Kim JH, Chipman CR, Panneton JM. Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia. J Vasc Surg. 2013;58:941\u20138.","journal-title":"J Vasc Surg."},{"key":"758_CR11","doi-asserted-by":"crossref","unstructured":"Zeller T, Beschorner U, Pilger E, Bosiers M, Deloose K, Peeters P, et al. Paclitaxel-coated balloon in infrapopliteal arteries: 12-month results from the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries). JACC Cardiovasc Interv. 2015; 8:1614\u20131622.","DOI":"10.1016\/j.jcin.2015.07.011"},{"issue":"31","key":"758_CR12","first-page":"1","volume":"7","author":"SE Haddad","year":"2017","unstructured":"Haddad SE, Shishani JM, Qtaish I, Rawashdeh MA, Qtaishat BS. One year primary patency of infrapopliteal angioplasty using drug-eluting balloons: single center experience at King Hussein Medical Center. J Clin Imaging Sci. 2017;7(31):1\u20135.","journal-title":"J Clin Imaging Sci."},{"key":"758_CR13","first-page":"707","volume":"59","author":"V Brizzi","year":"2018","unstructured":"Brizzi V, Caradu C, Berard X, Sassoust G, Midy D, Ducasse E. Six-year multicenter experience of standard endovascular treatment of critical limb ischemia in the era of drug-eluting devices. J Cardiovasc Surg (Torino). 2018;59:707\u201315.","journal-title":"J Cardiovasc Surg (Torino)."},{"key":"758_CR14","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1007\/s00270-019-02279-6","volume":"42","author":"U Teichgraber","year":"2019","unstructured":"Teichgraber U, Lehmann T, Thieme M, Wahl KU, Stelzner C, Bormann A, et al. Drug-coated balloon angioplasty of infrapopliteal lesions in patients with critical limb ischaemia: 1-year results of the APOLLO trial. Cardiovasc Intervent Radiol. 2019;42:1380\u201390.","journal-title":"Cardiovasc Intervent Radiol."},{"key":"758_CR15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","volume":"60","author":"A Rastan","year":"2012","unstructured":"Rastan A, Brechtel K, Krankenberg H, Zahorsky R, Tepe G, Noory E, et al. Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial. J Am Coll Cardiol. 2012;60:587\u201391.","journal-title":"J Am Coll Cardiol"},{"key":"758_CR16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1583\/11-3591MR.1","volume":"19","author":"JP Goltz","year":"2012","unstructured":"Goltz JP, Ritter CO, Kellersmann R, Klein D, Hahn D, Kickuth R. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force. J Endovasc Ther. 2012;19:450\u20136.","journal-title":"J Endovasc Ther."},{"key":"758_CR17","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/1526602815598955","volume":"22","author":"KL Schulte","year":"2015","unstructured":"Schulte KL, Pilger E, Schellong S, Tan KT, Baumann F, Langhoff R, et al. Primary self-EXPANDing nitinol stenting vs balloon angioplasty with optional bailout stenting for the treatment of infrapopliteal artery disease in patients with severe intermittent claudication or critical limb ischemia (EXPAND Study). J Endovasc Ther. 2015;22:690\u20137.","journal-title":"J Endovasc Ther."},{"key":"758_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5603\/AA.2018.0015","volume":"24","author":"P Potoczny","year":"2018","unstructured":"Potoczny P, Janik P, Uryniak A. Angioplasty of the popliteal artery using the Jaguar (TM) stent. Acta Angiologica. 2018;24:80\u20135.","journal-title":"Acta Angiologica."},{"key":"758_CR19","first-page":"183","volume":"51","author":"JO Balzer","year":"2010","unstructured":"Balzer JO, Zeller T, Rastan A, Sixt S, Vogl TJ, Lehnert T, et al. Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents. J Cardiovasc Surg (Torino). 2010;51:183\u201391.","journal-title":"J Cardiovasc Surg (Torino)."},{"key":"758_CR20","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.jvir.2010.09.011","volume":"21","author":"WD McMillan","year":"2010","unstructured":"McMillan WD, Leville CD, Long TD, Gomes M, Groffsky JL, Schultz SR. Drug-eluting tibial stents: objective patency determination. J Vasc Interv Radiol. 2010;21:1825\u20139.","journal-title":"J Vasc Interv Radiol."},{"key":"758_CR21","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1583\/10-3073.1","volume":"17","author":"A Rastan","year":"2010","unstructured":"Rastan A, Schwarzwalder U, Noory E, Taieb FH, Beschorner U, Sixt S, et al. Primary use of sirolimus-eluting stents in the infrapopliteal arteries. J Endovasc Ther. 2010;17:480\u20137.","journal-title":"J Endovasc Ther."},{"key":"758_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1583\/11-3665.1","volume":"19","author":"M Werner","year":"2012","unstructured":"Werner M, Schmidt A, Freyer M, Bausback Y, Braunlich S, Friedenberger J, et al. Sirolimus-eluting stents for the treatment of infrapopliteal arteries in chronic limb ischemia: long-term clinical and angiographic follow-up. J Endovasc Ther. 2012;19:12\u20139.","journal-title":"J Endovasc Ther."},{"key":"758_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijcard.2015.08.178","volume":"202","author":"E Stabile","year":"2016","unstructured":"Stabile E, Salemme L, Ferrone M, Arcari A, Cioppa A, Popusoi G, et al. Abluminal biodegradable polymer-based Biolimus A9-eluting stent for the treatment of infrapopliteal arteries in critical limb ischemia: Long-term follow-up. Int J Cardiol. 2016;202:98\u20139.","journal-title":"Int J Cardiol."},{"key":"758_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/1538574416689429","volume":"51","author":"A Giaquinta","year":"2017","unstructured":"Giaquinta A, Vincenzo A, De Marco E, Veroux M, Veroux P. Everolimus-eluting stent for patients with critical limb ischemia and infrapopliteal arterial occlusive disease. Vasc Endovascular Surg. 2017;51:60\u20136.","journal-title":"Vasc Endovascular Surg."},{"key":"758_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.116.004877","volume":"6","author":"MI Spreen","year":"2017","unstructured":"Spreen MI, Martens JM, Knippenberg B, van Dijk LC, de Vries JPM, Vos JA, et al. Long-term follow-up of the PADI trial: percutaneous transluminal angioplasty versus drug-eluting stents for infrapopliteal lesions in critical limb ischemia. J Am Heart Assoc. 2017;6:1\u201311.","journal-title":"J Am Heart Assoc."},{"key":"758_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/0301-5629(92)90082-L","volume":"18","author":"C Ranke","year":"1992","unstructured":"Ranke C, Creutzig A, Alexander K. Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol. 1992;18:433\u201340.","journal-title":"Ultrasound Med Biol."},{"key":"758_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/1358863x06070516","volume":"11","author":"M Gerhard-Herman","year":"2006","unstructured":"Gerhard-Herman M, Gardin JM, Jaff M, Mohler E, Roman M, Naqvi TZ, et al. Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med. 2006;11:183\u2013200.","journal-title":"Vasc Med."},{"key":"758_CR28","first-page":"E245","volume":"13","author":"CN Richards","year":"2016","unstructured":"Richards CN, Schneider PA. Explaining the discrepancy between lower patency and higher limb salvage rates after revascularization for critical limb ischemia. Vasc Dis Manag. 2016;13:E245\u201351.","journal-title":"Vasc Dis Manag"},{"key":"758_CR29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0301-5629(98)00103-3","volume":"24","author":"CK Holland","year":"1998","unstructured":"Holland CK, Brown JM, Scoutt LM, Taylor KJ. Lower extremity volumetric arterial blood flow in normal subjects. Ultrasound Med Biol. 1998;24:1079\u201386.","journal-title":"Ultrasound Med Biol."},{"key":"758_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/1526602817704643","volume":"24","author":"GD Singh","year":"2017","unstructured":"Singh GD, Brinza EK, Hildebrand J, Waldo SW, Foley TR, Laird JR, et al. Midterm outcomes after infrapopliteal interventions in patients with critical limb ischemia based on the TASC II classification of below-the-knee arteries. J Endovasc Ther. 2017;24:321\u201330.","journal-title":"J Endovasc Ther."}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-021-00758-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-021-00758-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-021-00758-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T11:14:30Z","timestamp":1643109270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-021-00758-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["758"],"URL":"https:\/\/doi.org\/10.1007\/s12928-021-00758-7","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,6]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"KS has received personal fees as honoraria from AstraZeneca and has received research funding from AstraZeneca, Nippon Boehringer Ingelheim, and Taiho Pharmaceutical. All other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study is a meta-analysis of research articles and do not involve human participants and\/or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving Human Participants and\/or Animals"}},{"value":"This study is a meta-analysis of research articles and do not require IRB review or informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}